TABLE 5.

Clinical outcomes for mice infected with ATCC 6303 and treated with moxifloxacin and levofloxacin

Disease severitya	Moxifloxacin			Levofloxacin
	Sample size	Temp (°C)b	Survival (%)	Sample size	Temp (°C)b	Survival (%)
Moderate	31	33.3 ± 0.7	31/31 (100)	42	33.5 ± 0.7	37/42 (88)c
Severe	27	31 ± 0.7	21/27 (78)	17	31 ± 0.2	12/17 (70)d

^aModerate surface temperature of ≥32°C; Severe, surface temperature of <32 to >30°C.

^bTemperature prior to treatment. Values are means ± standard deviations.

^cP = 0.07 compared with the value for the moxifloxacin group.

^dP = 0.72 compared with the value for the moxifloxacin group.